Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status.
Desislava TashkovaNevena IlievaDenitsa SertevaYana FeodorovaNikolay MehterovAngelina MollovaSvitlana BachurskaPublished in: Folia medica (2024)
Aberrant expression of CK7/CK20/CDX2 is reported in percentage of colorectal carcinomas (CRC).